MPH Health Care AG

XETRA 93M1.DE

MPH Health Care AG Market Capitalization on January 14, 2025: USD 104.13 M

MPH Health Care AG Market Capitalization is USD 104.13 M on January 14, 2025, a 38.05% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

MPH Health Care AG 52-week high Market Capitalization is USD 163.02 M on June 04, 2024, which is 56.55% above the current Market Capitalization.
MPH Health Care AG 52-week low Market Capitalization is USD 74.24 M on January 16, 2024, which is -28.71% below the current Market Capitalization.
MPH Health Care AG average Market Capitalization for the last 52 weeks is USD 109.07 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

XETRA: 93M1.DE

MPH Health Care AG

CEO	Mr. Patrick Brenske
IPO Date	May 16, 2011
Location	Germany
Headquarters	GrUenauer Strasse 5
Employees	2
Sector	Health Care
Industries Pharmaceuticals

Description

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.

Key trends

Past 5 years